Aadi Bioscience Inc

Company Profile

Aadi Bioscience Inc had its IPO on 2017-08-08 under the ticker symbol AADI.

The company operates in the Healthcare sector and Biotechnology industry. Aadi Bioscience Inc has a staff strength of 76 employees.

Stock update

Shares of Aadi Bioscience Inc opened at $5.67 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $5.57 - $5.96, and closed at $5.96.

This is a +5.58% increase from the previous day's closing price.

A total volume of 121,737 shares were traded at the close of the day’s session.

In the last one week, shares of Aadi Bioscience Inc have increased by +1.71%.

Aadi Bioscience Inc's Key Ratios

Aadi Bioscience Inc has a market cap of $219.56 million, indicating a price to book ratio of 1.8927 and a price to sales ratio of 28.1934.

In the last 12-months Aadi Bioscience Inc’s revenue was $10.99 million with a gross profit of $-18550000 and an EBITDA of $-59277000. The EBITDA ratio measures Aadi Bioscience Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Aadi Bioscience Inc’s operating margin was -540.81% while its return on assets stood at -20.47% with a return of equity of -39.12%.

In Q3, Aadi Bioscience Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 1822.5%.

Aadi Bioscience Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

2.3136

PEG

Its diluted EPS in the last 12-months stands at $3.89 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Aadi Bioscience Inc’s profitability.

Aadi Bioscience Inc stock is trading at a EV to sales ratio of 12.6288 and a EV to EBITDA ratio of -2.2324. Its price to sales ratio in the trailing 12-months stood at 28.1934.

Aadi Bioscience Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$194.10 million

Total Liabilities

$17.89 million

Operating Cash Flow

$-48243000.00

Capital Expenditure

$366000

Dividend Payout Ratio

0%

Aadi Bioscience Inc ended 2024 with $194.10 million in total assets and $0 in total liabilities. Its intangible assets were valued at $194.10 million while shareholder equity stood at $169.11 million.

Aadi Bioscience Inc ended 2024 with $0 in deferred long-term liabilities, $17.89 million in other current liabilities, 2000.00 in common stock, $-189285000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $134.82 million and cash and short-term investments were $183.01 million. The company’s total short-term debt was $374,000 while long-term debt stood at $0.

Aadi Bioscience Inc’s total current assets stands at $189.86 million while long-term investments were $0 and short-term investments were $48.19 million. Its net receivables were $2.26 million compared to accounts payable of $3.92 million and inventory worth $734000.00.

In 2024, Aadi Bioscience Inc's operating cash flow was $-48243000.00 while its capital expenditure stood at $366000.

Comparatively, Aadi Bioscience Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$5.96

52-Week High

$20.09

52-Week Low

$8.48

Analyst Target Price

$42.5

Aadi Bioscience Inc stock is currently trading at $5.96 per share. It touched a 52-week high of $20.09 and a 52-week low of $20.09. Analysts tracking the stock have a 12-month average target price of $42.5.

Its 50-day moving average was $5.94 and 200-day moving average was $8.89 The short ratio stood at 10.4 indicating a short percent outstanding of 0%.

Around 1164% of the company’s stock are held by insiders while 6430.2% are held by institutions.